Chemkart India Ltd — Important, 15-07-2026: Company Update

Chemkart India reported strong Q1 FY27 performance with revenue from operations at INR 99.60 Crore, achieving nearly 50% of last year's full-year revenue with improved margins. Its subsidiary, Vinstar Biotech, secured initial trial orders for in-house developed value-added ingredients, validating R&D capabilities and marking a shift towards proprietary formulations. The Easy Raw Materials manufacturing facility is progressing on schedule, with key civil work completed and power infrastructure secured. Chemkart is evolving from a distributor to an integrated, solutions-driven partner, investing in R&D and manufacturing to offer customised solutions and strengthen customer relationships.